Background: Heightened expression of the receptor for advanced glycation end products (RAGE) contributes to development of systemic diabetic complications, but its contribution to diabetic neuropathy is uncertain. Objective: We studied experimental diabetic neuropathy and its relationship with RAGE expression using streptozotocin (STZ) diabetic mice including a RAGE cohort exposed to long-term ...

In this fifth article in our ‘Test Tips’ series, Dr Katherine Bishop and Ruth Poole examine the relative benefits limitations of four commonly-used tests for diabetic peripheral neuropathy.

BACKGROUND Almost half of Diabetic Peripheral Neuropathies (DPNs) are symptom-free. Methods including questionnaires and electrodiagnosis (EDx) can be fruitful for easy reach to early diagnosis, correct treatments of diabetic neuropathy, and so decline of complications for instance diabetic foot ulcer and prevention of high costs. The goal of our study was to compare effectiveness of the Michig...

Objective To systematically evaluate the diagnostic accuracy of monofilament tests for detecting diabetic peripheral neuropathy. Methods We searched EMBASE (OvidSP), MEDLINE (OvidSP), the Cochrane Library, and Web of Science to identify diagnostic accuracy trials of monofilament tests for detecting diabetic peripheral neuropathy. We used a hierarchical summary receiver operating characteristi...

OBJECTIVE Heightened expression of the receptor for advanced glycation end products (RAGE) contributes to development of systemic diabetic complications, but its contribution to diabetic neuropathy is uncertain. We studied experimental diabetic neuropathy and its relationship with RAGE expression using streptozotocin-induced diabetic mice including a RAGE(-/-) cohort exposed to long-term diabet...

This study was undertaken to clinically estimate the prevalence of diabetic peripheral neuropathy amongst patients attending an outpatient clinic and to evaluate their risk factors for developing peripheral neuropathy. It was a cross-sectional study of 134 diabetes mellitus patients who attended the Primary Care Clinic, University Hospital, Kuala Lumpur. The patients were interviewed for their ...

abstract background: diabetic neuropathy is the most common micro-vascular complications of diabetes. the drugs including gabapentin and duloxetine are often used for the treatment of pain associated with diabetic neuropathy. this study aimed to compare the efficacy of duloxetine and gabapentin in the treatment of diabetic peripheral neuropathy. materials and methods: totally, 34 patients aged ...

normal 0 false false false en-us x-none ar-sa background: diabetes mellitus (dm) is a common metabolic disorder that can cause various complications including, peripheral neuropathy (pnp). some possible risk-factors such as blood glucose level, hyperglycemia, duration of diabetes, and lipid profiles are assumed to be important in diabetic pnp incidence. the aim of this study is to evaluate the ...

We previously demonstrated that treatment of diabetic peripheral neuropathy with the short (4 hours) half-life phosphodiesterase 5 (PDE5) inhibitor, sildenafil, improved functional outcome in diabetic db/db mice. To further examine the effect of PDE5 inhibition on diabetic peripheral neuropathy, we investigated the effect of another potent PDE5 inhibitor, tadalafil, on diabetic peripheral neuro...

Neuropathic pain is a common symptom in the elderly and tends to increase according frequency of related underlying disease. In older patients, cognitive decline accompanying medical conditions may make early diagnosis difficult. Therefore, detailed history taking, neurological examination, laboratory tests should be performed. Diabetic peripheral neuropathy, entrapment radiculopathy, postherpe...